13-24434505-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006437.4(PARP4):c.4636G>A(p.Asp1546Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000204 in 1,613,808 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006437.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PARP4 | NM_006437.4 | c.4636G>A | p.Asp1546Asn | missense_variant | 31/34 | ENST00000381989.4 | NP_006428.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PARP4 | ENST00000381989.4 | c.4636G>A | p.Asp1546Asn | missense_variant | 31/34 | 1 | NM_006437.4 | ENSP00000371419 | P1 | |
TPTE2P6 | ENST00000445572.5 | n.233+25201C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152214Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251328Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135828
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461594Hom.: 0 Cov.: 38 AF XY: 0.00000825 AC XY: 6AN XY: 727090
GnomAD4 genome AF: 0.000105 AC: 16AN: 152214Hom.: 0 Cov.: 33 AF XY: 0.0000941 AC XY: 7AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2024 | The c.4636G>A (p.D1546N) alteration is located in exon 31 (coding exon 30) of the PARP4 gene. This alteration results from a G to A substitution at nucleotide position 4636, causing the aspartic acid (D) at amino acid position 1546 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at